Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Virology|August 17, 2022
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and AdultsSneh Lata Gupta, Grace Mantus, Kelly E Manning, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2021
Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding DomainGrace Mantus, Lindsay E Nyhoff, Robert C Kauffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
Altered amino acid profile in patients with SARS-CoV-2 infectionChris A Rees, Christina A Rostad, Grace Mantus, et al.
Vaccines|February 26, 2025
Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare WorkersDunia Hatabah, Sneh Lata Gupta, Grace Mantus, et al.
Virology|March 11, 2021
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from IndiaKaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 16, 2021
Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workersClaudia R Morris, Patrick Sullivan, Grace Mantus, et al.
Pediatrics|September 4, 2020
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C)Christina A Rostad, Ann Chahroudi, Grace Mantus, et al.
Structure (London, England : 1993)|May 11, 2023
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody responseAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody responseAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.
Cell Reports. Medicine|March 2, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Pageof 4